Ultragenyx Pharmaceutical | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
Agios Pharmaceuticals USD -127056000 20.43M 2025-06
Alnylam Pharmaceuticals USD -16199000 34.28M 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Insmed USD -253876000 5.74M 2025-06
Ionis Pharmaceuticals USD 139.84M 285.84M 2025-06
Kyowa Hakko Kirin JPY 12.82B 5.39B 2025-06
MacroGenics USD -16587000 70.78M 2024-12
Moderna USD -907000000 143M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
PTC Therapeutics USD -34858000 1.01B 2025-06
Regeneron Pharmaceuticals USD 1.08B 487.8M 2025-06
Sarepta Therapeutics USD 115.58M 415.96M 2025-06
Ultragenyx Pharmaceutical USD -193567000 50.63M 2025-06
Vertex Pharmaceuticals USD 1.15B 123.1M 2025-06


Ultragenyx Pharmaceutical Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.